Five things to know:
1. The company reported a 1.2 percent decline in sales in the Americas, hitting $1.2 billion. The company also reported a 6.6 percent sales decline in the EMEA and 1.4 percent sales increase in the Asia Pacific.
2. Knee sales were down 2.7 percent in the quarter, hitting $694 million overall. Knee sales in the Americas dropped nearly 2 percent to $409 million.
3. Hip sales were relatively flat in the Americas, dropping 0.3 percent to $247 million. Overall, hip sales were down 1.6 percent to $484 million.
4. Spine and craniomaxillofacial sales were flat at $183 million for the quarter.
5. In the first quarter, Zimmer Biomet paid down $110 million of debt and plans to use most of its $284 million cash flow to continue decreasing debt throughout the year.
More articles on orthopedic devices:
Stryker Q1 spine sales up 38.6% in US after K2M acquisition: 6 things to know
12 device makers prepare pitches for judgets from Medtronic, DePUy Synthes & more
Fitch: 5 trends to watch in device company M&A
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
